The complex genetic heterogeneity and the overlapping phenotypes between patients with classic HHT and those harboring RASA1 and GDF2 mutations may make it difficult for clinicians to accurately identify the molecular lesion underlying the clinical presentation. Here, GDF2 is linked to hereditary hemorrhagic telangiectasia.